Lipella Pharmaceuticals Inc.
10/09/2025 | Press release | Distributed by Public on 10/09/2025 15:01
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 3, 2025, Dr. Michael Chancellor notified Lipella Pharmaceuticals Inc. (the "Company") of his intention to retire from his positions as the Company's Chief Medical Officer and a member of the Company's Board of Directors, effective December 4, 2025. Dr. Chancellor's decision to retire did not result from any disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Lipella Pharmaceuticals Inc. published this content on October 09, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT) on October 09, 2025 at 21:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]